Zero-cost Radiation Protection Method to Reduce Radiation Exposure of Interventional Cardiologists During Transradial Percutaneous Coronary Procedures (FREEPADRAD Trial)

Launched by NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS · Apr 9, 2025

Keywords

ClinConnect Summary

The FREEPADRAD Trial is a study aimed at finding a better way to protect doctors from radiation during certain heart procedures. When interventional cardiologists perform procedures like coronary angiography (a test to see how well the heart is working) or angioplasty (a procedure to open blocked blood vessels), they are exposed to ionising radiation, which can be harmful over time. This trial is looking at whether using medical lead aprons, typically worn by medical staff for protection, can help reduce the radiation exposure to the doctors when placed over the patient’s lower abdomen and pelvis during these procedures.

To participate in this trial, patients should be adults aged 18 and older who are scheduled for a transradial coronary angiography or angioplasty. However, those with certain conditions, like a heart emergency that requires immediate intervention or those who cannot give their consent, won't be eligible. Participants can expect to have their radiation exposure measured to see if the lead aprons make a difference in protecting the medical staff. Overall, this trial is important for improving safety in heart procedures for both patients and healthcare providers.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing transradial diagnostic coronary angiography or angioplasty.
• • Adults aged 18 years and older.
• • Informed consent provided.
• Exclusion Criteria:
• • Acute STEMI requiring primary percutaneous coronary intervention (PCI).
• • Patients undergoing structural heart interventions.
• • Initially femoral access or crossover to femoral access procedures.
• • Patients unable to provide informed consent.